Hemochromatosis
Hereditary hemochromatosis: the importance of early genetic diagnosis
Hereditary hemochromatosis is a genetic disease characterized by excessive intestinal absorption of iron, which can lead to its progressive accumulation in organs and tissues. Over time, iron overload can damage the liver, pancreas, heart, joints and endocrine glands, impairing their function and the patient’s quality of life.
The most common form in populations of European origin is associated with alterations in the HFE gene, which is involved in the regulation of iron metabolism. The variants analyzed in genetic tests include C282Y, H63D and S65C. The clinical significance of the result varies according to the variant and the combination of variants detected: the presence of one of them alone does not necessarily indicate that the person will develop the disease.
Explore solutions for the genetic diagnosis of hemochromatosis
Browse the products available for the analysis of HFE gene variants and find the solutions best suited to your laboratory’s needs.
The role of genetic analysis in diagnosis
Hereditary hemochromatosis has a genetic component. The identification of the variants associated with the disease can support the assessment of patients with suspected iron overload and the evaluation of at-risk family members.
<p>Molecular analysis is a useful tool to:</p>
<ul>
<li>support diagnosis in patients with alterations of iron metabolism;</li>
<li>identify individuals with a genetic predisposition;</li>
<li>carry out family evaluations in relatives of affected patients;</li>
<li>support genetic counseling;</li>
<li>promote early and personalized clinical management.</li>
</ul>
<p>The genetic result should be interpreted together with biochemical tests, in particular transferrin saturation and ferritin, and with the patient’s clinical picture. This integration allows a more accurate assessment than the isolated evaluation of a genetic variant.</p>
Early diagnosis and prevention of hereditary hemochromatosis
<p>In the early stages, hemochromatosis may be asymptomatic. Iron accumulates gradually and symptoms may appear when organ damage is already present. If not identified and treated, the disease can progress to serious complications, including liver cirrhosis, heart failure and, in patients with advanced liver damage, hepatocellular carcinoma.</p>
<p>Recognizing iron overload in its early stages makes it possible to start the appropriate clinical pathway before significant damage develops. Evaluating the family members of an affected person can also help identify those who need further investigation or monitoring.</p>
<p>In this pathway, genetic screening is integrated with iron tests and specialist counseling. Molecular tests make it possible to identify the HFE gene variants investigated, including C282Y, H63D and S65C. Nuclear Laser Medicine offers solutions dedicated to this analysis.</p>
<p>Knowledge of the genetic profile helps define individual risk, while biochemical parameters such as ferritin and transferrin saturation help assess any iron accumulation. Considered together with the clinical picture, these data support more timely and personalized patient management.</p>
Solutions for the genetic diagnosis of hemochromatosis
Explore the Nuclear Laser Medicine products dedicated to the analysis of HFE gene variants. For information on the variants investigated and on the solutions best suited to your laboratory’s needs, contact us.